Philip Morris price target raised to $182 from $168 at UBS
UBS raised the firm’s price target on Philip Morris (PM) to $182 from $168 and keeps a Neutral rating on the shares.
Fiscal Year: January - December
Philip Morris International Inc. (PM), listed on the NYSE, has a market capitalization of $292.68B. As of Jul 07, 2026, the stock is trading at $187.79 per share@else an unavailable price , offering investors a clear view of its current market value. Philip Morris International Inc. is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 26.02, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. Philip Morris International Inc. also offers a dividend yield of 3.13%, making it an attractive option for income-focused investors who seek regular dividends.
DCF analysis data is not yet available for Philip Morris International Inc. (PM). The fair value estimate will be displayed once sufficient analyst forecast data is collected.
The proprietary SS Score for Philip Morris International Inc. is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for Philip Morris International Inc., Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for Philip Morris International Inc. is 27.44, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, Philip Morris International Inc. (PM) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether Philip Morris International Inc. (PM) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. It is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of Philip Morris International Inc. (PM) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of Philip Morris International Inc.. To access the full SS Score, consider upgrading your subscription.
Philip Morris International Inc. is a significant player in the industry sector, with a market capitalization of $292.68B and a competitive P/E ratio of 26.02. Investors should compare these metrics with industry peers to gauge whether Philip Morris International Inc. is outperforming or underperforming within its sector.
UBS raised the firm’s price target on Philip Morris (PM) to $182 from $168 and keeps a Neutral rating on the shares.
Philip Morris stock earned bullish analyst ratings on Wednesday following a tobacco risk update from the FDA.
Federal regulator gives Philip Morris International a win for nicotine pouches.
The FDA will allow 20 Philip Morris-owned Zyn nicotine pouch products to carry a modified-risk claim saying switching from cigarettes lowers the risk of several smoking-related diseases. The decision ...
Philip Morris (PM) International announced that the U.S. Food and Drug Administration issued Modified Risk Tobacco Product orders for 20 variants of ZYN nicotine pouch products. “These are the first…
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for...
The U.S. Food and Drug Administration said on Tuesday it would allow Philip Morris to market its Zyn nicotine pouches as less harmful than cigarettes.
The U.S. Food and Drug Administration proposed a rule on Friday that would require foreign tobacco product makers to register their facilities and list products sold in the country.
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) has been named in the WSJ Leadership Institute's inaugural “Best Companies for the Future” ranking, which evaluates lar...
STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE: PM) today declared a regular quarterly dividend of $1.47 per common share, payable on ...
Italy’s competition authority, AGCM, has fined Philip Morris’ ($PM) Italian unit €7 million ($8.1 million) for allegedly misleading marketing of non-combustion tobacco offerings. The company said that...
Italy's competition authority on Wednesday slapped a €7 million ($8.1 million) fine on Philip Morris' Italian unit over allegedly misleading marketing for non-combustion tobacco products.
Morgan Stanley raised the firm’s price target on Philip Morris (PM) to $200 from $190 and keeps an Overweight rating on the shares. Philip Morris’ announcement at an investor conference…
STAMFORD, CT--(BUSINESS WIRE)--A new study detailing the scale of the illicit cigarette trade in the European Union (EU) shows that consumption of black-market cigarettes rose more than 7% year-on-yea...
Philip Morris cut its annual profit forecast on Tuesday, with CEO Jacek Olczak citing margin pressure due to higher energy costs from the Iran conflict and currency swings, at a time when consumers ...
Philip Morris International said it is booking a roughly $500 million impairment charge in the second quarter to reduce the carrying value of its investment in Canadian affiliate Rothmans Benson & Hed...
Consensus $8.41. Philip Morris (PM)’ Group CEO PMI, Jacek Olczak, will address investors at the 2026 dbAccess Global Consumer Conference in Paris. The company said, “PMI updates its 2026 full-year…
STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc.'s (PMI) (NYSE: PM) Group CEO PMI, Jacek Olczak, will address investors today at the 2026 dbAccess Global Consumer Confe...
Historically, energy stocks have performed the best when inflation spikes.
Bearish flow noted in Philip Morris (PM) with 3,315 puts trading, or 1.3x expected. Most active are Jun-26 175 puts and 5/29 weekly 177.5 puts, with total volume in those…
STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will host a live webcast of the company's remarks and Q&A session with Jacek Olczak, Group CEO PMI, at...
The U.S. FDA's new, looser regulation of new vapes and nicotine pouches will potentially unleash hundreds more such products on the market in the coming weeks and months, according to three current a...
STAMFORD, Conn.--(BUSINESS WIRE)--Philip Morris International's (PMI) (NYSE: PM) IQOS, the #1 tobacco heating system1, has been listed for the first time as one of the top 100 most valuable brands in ...
BofA analyst Lisa Lewandowski raised the firm’s price target on Philip Morris (PM) to $209 from $200 and keeps a Buy rating on the shares. The firm views the recent…
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.